Cullinan Therapeutics CGEM
NASDAQ CGEM
$11.35 +0.12 (+1.07%)
At close: Nov 11, 2026 · 4:00 PM EST

Cullinan Therapeutics (CGEM) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Cullinan Therapeutics (CGEM) reported Return on Capital Employed [ROCE] of -64.71% for Q2 2026, down 19.75 percentage points from -44.97% a year earlier and down 3.17 percentage points from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics posted Return on Capital Employed [ROCE] of -48.59%, down 10.89 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of -26.96 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -37.70% in FY2024 (+0.94 pp), -38.64% in FY2023 (-68.99 pp), 30.35% in FY2022 (+51.97 pp) and -21.63% in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -10.44 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2023 (a gain of 46.66 percentage points); the low point was Q4 2023 (a drop of 66.95 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -61.55% (Q1 2026), -56.39% (Q4 2025) and -51.43% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Cullinan Therapeutics 722.60 Mn -1.13 Bn - -72.20%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -72.20%
Jun 30, 2026 -64.71%
Mar 31, 2026 -61.55%
Dec 31, 2025 -56.39%
Sep 30, 2025 -51.43%
Jun 30, 2025 -44.97%
Mar 31, 2025 -36.44%
Dec 31, 2024 -32.45%
Sep 30, 2024 -29.14%
Jun 30, 2024 -33.91%
Mar 31, 2024 -38.51%
Dec 31, 2023 -41.42%
Sep 30, 2023 -36.75%
Jun 30, 2023 -32.62%
Mar 31, 2023 22.38%
Dec 31, 2022 25.53%
Sep 30, 2022 23.23%
Jun 30, 2022 31.47%
Mar 31, 2022 -24.28%
Dec 31, 2021 -15.67%
API Access

Cullinan Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CGEM&period=max&api_key=YOUR_API_KEY